BMN-355

N/A

Report date: 2024/05/20 10:13:13

Base Information

Drug NameBMN-355
Drug Alias NameBMN 355BMN-355
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionIon channels modulators
TargetsIon channels
Therapy Area/IndicationsLong QT Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaN/A
Originator CompaniesBiomarin Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomarin Pharmaceutical Inc
Active IndicationsN/A
Inactive IndicationsLong QT Syndrome

Other Information

ATC CodeN/A
Related LinksN/A